Literature DB >> 22949090

AT2 receptors: beneficial counter-regulatory role in cardiovascular and renal function.

Shetal H Padia1, Robert M Carey.   

Abstract

The renin-angiotensin system (RAS) is a coordinated hormonal cascade intimately involved in cardiovascular and renal control and blood pressure regulation. Angiotensin II (Ang II), the major RAS effector peptide, binds two distinct receptors, the angiotensin type-1 receptor (AT(1)R) and the angiotensin type-2 (AT(2)R) receptor. The vast majority of the physiological actions of Ang II, almost all of them detrimental, are mediated by AT(1)Rs. In contrast, AT(2)Rs negatively modulate the actions of AT(1)Rs under the majority of circumstances and generally possess beneficial effects. AT(2)Rs induce vasodilation in both resistance and capacitance vessels, mediating natriuresis directly and via interactions with dopamine D1 receptors in the renal proximal tubule. AT(2)Rs inhibit renin biosynthesis and secretion and protect the kidneys from inflammation and ischemic injury. Our understanding of the exact role of AT(2)Rs in physiology and pathophysiology continues to expand; the purpose of this review is to provide an up-to-date summary of the functional role of AT(2)Rs at the organ, tissue, cellular, and subcellular levels with emphasis on the vascular and renal actions that bear on blood pressure regulation and hypertension.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22949090      PMCID: PMC3548020          DOI: 10.1007/s00424-012-1146-3

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  78 in total

1.  Gender differences in pressure-natriuresis and renal autoregulation: role of the Angiotensin type 2 receptor.

Authors:  Lucinda M Hilliard; Mehdi Nematbakhsh; Michelle M Kett; Elleesha Teichman; Amanda K Sampson; Robert E Widdop; Roger G Evans; Kate M Denton
Journal:  Hypertension       Date:  2010-12-28       Impact factor: 10.190

2.  Angiotensin AT₂ receptor stimulation inhibits early renal inflammation in renovascular hypertension.

Authors:  Luis C Matavelli; Jiqian Huang; Helmy M Siragy
Journal:  Hypertension       Date:  2010-12-28       Impact factor: 10.190

3.  Angiotensin II stimulates thick ascending limb NO production via AT(2) receptors and Akt1-dependent nitric-oxide synthase 3 (NOS3) activation.

Authors:  Marcela Herrera; Jeffrey L Garvin
Journal:  J Biol Chem       Date:  2010-03-18       Impact factor: 5.157

4.  Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice.

Authors:  Sonja Tesanovic; Antony Vinh; Tracey A Gaspari; David Casley; Robert E Widdop
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-05-06       Impact factor: 8.311

5.  Glucocorticoid-induced fetal programming alters the functional complement of angiotensin receptor subtypes within the kidney.

Authors:  TanYa M Gwathmey; Hossam A Shaltout; James C Rose; Debra I Diz; Mark C Chappell
Journal:  Hypertension       Date:  2011-01-10       Impact factor: 10.190

6.  Angiotensin III stimulates aldosterone secretion from adrenal gland partially via angiotensin II type 2 receptor but not angiotensin II type 1 receptor.

Authors:  Junichi Yatabe; Minoru Yoneda; Midori S Yatabe; Tsuyoshi Watanabe; Robin A Felder; Pedro A Jose; Hironobu Sanada
Journal:  Endocrinology       Date:  2011-02-08       Impact factor: 4.736

7.  Inhibition of NAD(P)H oxidase potentiates AT2 receptor agonist-induced natriuresis in Sprague-Dawley rats.

Authors:  Rifat Sabuhi; Mohammad Asghar; Tahir Hussain
Journal:  Am J Physiol Renal Physiol       Date:  2010-07-28

8.  Stimulation of angiotensin AT2 receptors by the non-peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats.

Authors:  S Bosnyak; I K Welungoda; A Hallberg; M Alterman; R E Widdop; E S Jones
Journal:  Br J Pharmacol       Date:  2010-01-28       Impact factor: 8.739

Review 9.  Mechanisms of tissue injury in renal artery stenosis: ischemia and beyond.

Authors:  Lilach O Lerman; Stephen C Textor; Joseph P Grande
Journal:  Prog Cardiovasc Dis       Date:  2009 Nov-Dec       Impact factor: 8.194

10.  Nuclear angiotensin II type 2 (AT2) receptors are functionally linked to nitric oxide production.

Authors:  Tanya M Gwathmey; Hossam A Shaltout; Karl D Pendergrass; Nancy T Pirro; Jorge P Figueroa; James C Rose; Debra I Diz; Mark C Chappell
Journal:  Am J Physiol Renal Physiol       Date:  2009-02-25
View more
  44 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

2.  Metabolic reprogramming by N-acetyl-seryl-aspartyl-lysyl-proline protects against diabetic kidney disease.

Authors:  Swayam Prakash Srivastava; Julie E Goodwin; Keizo Kanasaki; Daisuke Koya
Journal:  Br J Pharmacol       Date:  2020-06-22       Impact factor: 8.739

3.  Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson's Disease Models.

Authors:  Pablo Garrido-Gil; Ana I Rodriguez-Perez; Antonio Dominguez-Meijide; Maria J Guerra; Jose L Labandeira-Garcia
Journal:  Mol Neurobiol       Date:  2018-02-05       Impact factor: 5.590

4.  Structural libraries of protein models for multiple species to understand evolution of the renin-angiotensin system.

Authors:  Jeremy W Prokop; Victoria Petri; Mary E Shimoyama; Ingrid K M Watanabe; Dulce E Casarini; Thomas C Leeper; Stephanie M Bilinovich; Howard J Jacob; Robson A S Santos; Almir S Martins; Fabiano C Araujo; Fernando M Reis; Amy Milsted
Journal:  Gen Comp Endocrinol       Date:  2014-09-26       Impact factor: 2.822

5.  Interconversion of Functional Activity by Minor Structural Alterations in Nonpeptide AT2 Receptor Ligands.

Authors:  Charlotta Wallinder; Christian Sköld; Milad Botros; Marie-Odile Guimond; Mathias Hallberg; Nicole Gallo-Payet; Anders Karlén; Mathias Alterman
Journal:  ACS Med Chem Lett       Date:  2014-12-08       Impact factor: 4.345

6.  Angiotensin receptor expression revealed by reporter mice and beneficial effects of AT2R agonist in retinal cells.

Authors:  Amrisha Verma; Ping Zhu; Annette de Kloet; Eric Krause; Colin Sumners; Qiuhong Li
Journal:  Exp Eye Res       Date:  2019-08-23       Impact factor: 3.467

7.  AT2 Receptor Activation Prevents Sodium Retention and Reduces Blood Pressure in Angiotensin II-Dependent Hypertension.

Authors:  Brandon A Kemp; Nancy L Howell; Susanna R Keller; John J Gildea; Shetal H Padia; Robert M Carey
Journal:  Circ Res       Date:  2016-06-20       Impact factor: 17.367

Review 8.  Blood Pressure and the Renal Actions of AT2 Receptors.

Authors:  Robert M Carey
Journal:  Curr Hypertens Rep       Date:  2017-03       Impact factor: 5.369

9.  Angiotensin II type 2 receptor inhibits expression and function of insulin receptor in rat renal proximal tubule cells.

Authors:  Yang Yang; Caiyu Chen; Chunjiang Fu; Zaicheng Xu; Cong Lan; Yongchun Zeng; Zhi Chen; Pedro A Jose; Ye Zhang; Chunyu Zeng
Journal:  J Am Soc Hypertens       Date:  2017-12-06

10.  AT2R autoantibodies block angiotensin II and AT1R autoantibody-induced vasoconstriction.

Authors:  Campbell Liles; Hongliang Li; Vineet Veitla; Jonathan T Liles; Taylor A Murphy; Madeleine W Cunningham; Xichun Yu; David C Kem
Journal:  Hypertension       Date:  2015-08-10       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.